ARS Pharmaceuticals Inc’s recently made public that its Director Thompson Peter A. unloaded Company’s shares for reported $1.09 million on Aug 26 ’24. In the deal valued at $13.00 per share,83,695 shares were sold. As a result of this transaction, Thompson Peter A. now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ORBIMED ADVISORS LLC sold 83,695 shares, generating $1,088,035 in total proceeds. Upon selling the shares at $13.00, the Director now owns 0 shares.
Before that, Thompson Peter A. sold 407,700 shares. ARS Pharmaceuticals Inc shares valued at $5,526,601 were divested by the Director at a price of $13.56 per share. As a result of the transaction, Thompson Peter A. now holds 544,677 shares, worth roughly $7.07 million.
Cantor Fitzgerald initiated its ARS Pharmaceuticals Inc [SPRY] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in mid August from “an Outperform” to “a Strong buy”. Leerink Partners also remained covering SPRY and reiterated its “an Outperform” recommendation on August 12, 2024. Raymond James started covering the stock on July 25, 2024. It rated SPRY as “an Outperform”.
Price Performance Review of SPRY
On Friday, ARS Pharmaceuticals Inc [NASDAQ:SPRY] saw its stock unchanged to $12.98. Over the last five days, the stock has gained 0.15%. ARS Pharmaceuticals Inc shares have risen nearly 136.86% since the year began. Nevertheless, the stocks have risen 82.56% over the past one year. While a 52-week high of $16.50 was reached on 08/20/24, a 52-week low of $2.55 was recorded on 01/04/24. SMA at 50 days reached $10.94, while 200 days put it at $8.37.
Levels Of Support And Resistance For SPRY Stock
The 24-hour chart illustrates a support level at 12.64, which if violated will result in even more drops to 12.30. On the upside, there is a resistance level at 13.21. A further resistance level may holdings at 13.43. The Relative Strength Index (RSI) on the 14-day chart is 55.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.43%. Stochastics %K at 43.96% indicates the stock is a holding.
How much short interest is there in ARS Pharmaceuticals Inc?
A steep rise in short interest was recorded in ARS Pharmaceuticals Inc stocks on 2024-08-15, growing by 3.33 million shares to a total of 12.07 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 8.74 million shares. There was a rise of 27.57%, which implies that there is a positive sentiment for the stock.
